alkeuspharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /cgi-bin/ Disallow: | ||
Meta Tags
| Title | Alkeus Pharmaceuticals | Treating Serious Causes of |
| Description | Alkeus Pharmaceuticals is a late-stage company developing treatments for serious causes of blindness. Alkeus’ Lead Product, ALK-001, is a chemically-modified vitamin A that slows formation of toxic vitamin A |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 34.196.230.155 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
alkeuspharma.com Valuation
|
US$5,434,191
Last updated: 2023-05-07 18:18:39
alkeuspharma.com has Semrush global rank of 1,947,724. alkeuspharma.com has an estimated worth of US$ 5,434,191, based on its estimated Ads revenue. alkeuspharma.com receives approximately 627,022 unique visitors each day. Its web server is located in United States, with IP address 34.196.230.155. According to SiteAdvisor, alkeuspharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,434,191 |
| Daily Ads Revenue | US$5,017 |
| Monthly Ads Revenue | US$150,486 |
| Yearly Ads Revenue | US$1,805,824 |
| Daily Unique Visitors | 41,802 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| alkeuspharma.com. | A | 7200 | IP: 34.196.230.155 |
| alkeuspharma.com. | NS | 7200 | NS Record: ns2.hostica.com. |
| alkeuspharma.com. | NS | 7200 | NS Record: ns3.hostica.com. |
| alkeuspharma.com. | NS | 7200 | NS Record: ns1.hostica.com. |
| alkeuspharma.com. | MX | 7200 | MX Record: 500 s360.use3.mysecurecloudhost.com. |
HtmlToTextCheckTime:2023-05-07 18:18:39
| Strength in Sight November 29, 2021 Alkeus Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conferencee July 14, 2021 FDA Grants Alkeus Pharmaceuticals Breakthrough Therapy Designation for ALK-001 (C20-D3-vitamin A) for the Treatment of Stargardt Disease Alkeus Pharmaceuticals is a late-stage biopharmaceutical company developing transformative therapies to prevent blindness. Learn More » ALK-001 ALK-001 (C20-D3-vitamin A) is a chemically-modified form of vitamin A. Learn More » Pipeline Preventing vision loss caused by serious, progressive retinal degenerative diseases. Learn More » For Patients Ongoing clinical trials for patients diagnosed with Stargardt or age-related macular degeneration (AMD). Learn More » About Science Pipeline ALK-001 Patients Clinical Trials Stargardt Disease Geographic Atrophy News Careers Contact LinkedIn Twitter About Science Pipeline ALK-001 Patients Clinical Trials Stargardt Disease Geographic Atrophy News Careers Contact © 2021 Alkeus |
HTTP Headers
HTTP/1.1 200 OK Connection: Keep-Alive Keep-Alive: timeout=5, max=100 content-type: text/html last-modified: Wed, 14 Jul 2021 03:33:41 GMT accept-ranges: bytes content-length: 19379 date: Thu, 28 Oct 2021 12:48:41 GMT server: LiteSpeed vary: User-Agent |
alkeuspharma.com Whois Information
Domain Name: ALKEUSPHARMA.COM Registry Domain ID: 1585778112_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-02-18T15:10:38Z Creation Date: 2010-02-17T22:34:35Z Registry Expiry Date: 2022-02-17T22:34:35Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.HOSTICA.COM Name Server: NS2.HOSTICA.COM Name Server: NS3.HOSTICA.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T05:17:06Z <<< |